Characteristics and Unexpected COVID-19 Diagnoses in Resuscitation Room Patients during the COVID-19 Outbreak—A Retrospective Case SeriesClinical Study Published on 2020-08-172022-10-27 Journal: BioMed Research International [Category] [키워드] “COVID-19 acute respiratory syndrome analyzed Chest computed tomography Chest CT coronavirus disease Coronavirus-2 COVID-19 Critically ill Critically ill patient defined diagnostic outcome diagnostic outcomes differential diagnosis emergency department equipment Germany ground-glass opacity hospital Infection initial Intubated knowledge outbreak Patient patients pharyngeal Pharyngeal swab polymerase chain positive Protective pulmonary abscess Result Resuscitation Retrospective study room SARS-CoV-2 SARS-COV-2 infection Sery subgroup suspicious patients swabs Symptom tested tracheal trauma [DOI] 10.1155/2020/2721381 PMC 바로가기 [Article Type] Clinical Study
Characteristics and Unexpected COVID-19 Diagnoses in Resuscitation Room Patients during the COVID-19 Outbreak—A Retrospective Case SeriesClinical Study Published on 2020-08-172022-10-27 Journal: BioMed Research International [Category] COVID-19, MERS, SARS, [키워드] “COVID-19 acute respiratory syndrome analyzed Chest computed tomography Chest CT coronavirus disease Coronavirus-2 COVID-19 Critically ill Critically ill patient defined diagnostic outcome diagnostic outcomes differential diagnosis emergency department equipment Germany ground-glass opacity hospital Infection initial Intubated knowledge outbreak Patient patients pharyngeal Pharyngeal swab polymerase chain positive Protective pulmonary abscess Result Resuscitation Retrospective study room SARS-CoV-2 SARS-COV-2 infection Sery subgroup suspicious patients swabs Symptom tested tracheal trauma [DOI] 10.1155/2020/2721381 PMC 바로가기 [Article Type] Clinical Study
Managing humidity support in intubated ventilated patients with coronavirus disease 2019 (COVID-19)Letter to the Editor Published on 2020-08-122022-10-30 Journal: Infection Control and Hospital Epidemiology [Category] Coronavirus, MERS, SARS, [키워드] coronavirus disease COVID-19 Intubated managing Support ventilated patient [DOI] 10.1017/ice.2020.418 PMC 바로가기 [Article Type] Letter to the Editor
A Case Report: Co-presenting COVID-19 Infection and Acute Drug IntoxicationCOVID-19 Case Report Published on 2020-08-012022-10-31 Journal: Clinical Practice and Cases in Emergency Medicine [Category] COVID-19, [키워드] Admission airway Altered mental status anchoring bias Atypical atypical symptom Blood candidate Chest clinician Computed tomography Coronavirus disease 2019 cough Course COVID-19 COVID-19 in patient COVID-19 test COVID-19 testing discharged Drug Intoxication etiology fatigue Fever Ground-glass opacities Hypoxemia hypoxic include Incubation period interstitial Intubated lethargic male myalgia official opiate Opiates Patient positive presenting protocol raising report respiratory acidosis Shortness of breath Spread the disease Treatment ventilator [DOI] 10.5811/cpcem.2020.6.47764 PMC 바로가기 [Article Type] COVID-19 Case Report
Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDSCase Report Published on 2020-07-272022-10-30 Journal: Medicina [Category] COVID-19, SARS, [키워드] acute respiratory distress acute respiratory distress syndrome (ARDS) Antiviral approach ARDS BMI C-reactive protein calibrated Case report cells clinical condition Coagulation Combination Combined COVID-19 COVID-19 patient Cytokines decrease dropped Dyspnea effort Endothelium Fever hypoxia IL-6 IL-6 receptor immune-mediated inflammation Immunotherapy IMV Inflammation Inflammatory interfere interleukin-6 Intubated Invasive mechanical ventilation Laboratory limit male management monoclonal antibody Neutrophil-to-lymphocyte ratio NIV NLR non-invasive ventilation outcomes Oxygenation P/F P/F ratio PaO Pathogenesis Patient Pneumonia prone positioning Rapid reducing reported response suggested syndrome TCZ therapy Tocilizumab treated Treatment ventilatory strategy with COVID-19 worsening [DOI] 10.3390/medicina56080377 PMC 바로가기 [Article Type] Case Report
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-07-132022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 24 hour 48 hour Activation acute lung injury acute pneumonia acute respiratory distress syndrome Administered Adult age all-cause mortality Amendment antibodies antibody Antibody test anticipated antiviral therapy approval ARDS assessment assigned baseline Biomarker Blood cardiac disease Care change class Clinical improvement clinical study clinical trial complement Complement inhibitor component Computed tomography concealed Concentration conducted Confirmed Controlled coronary syndrome COVID-19 criteria current Day diagnosis of SARS-CoV-2 dialysis discharge dissemination dose Duration Efficacy element eligibility Endotracheal intubation EU Clinical Trial EudraCT evaluate the effect expected failure female patient Final fraction France Germany greater half-live hospital Hospitalization humanized Hypercoagulable state Immunoglobulin Infection Inflammatory inhibitor initiated intensive care Intubated intubation invasive Invasive mechanical ventilation investigator IVIG Japan Lung injury mechanical ventilation medication monoclonal multicenter Neisseria meningitidis Non-invasive number objective Open-label original outcome oxygen participant Patient patients randomized patients with COVID-19 Period peripheral capillary phase Placebo Pneumonia polymerase chain positive airway pressure presenting progression protocol randomised randomised controlled trial randomization randomization list Randomized randomized controlled study Randomly Ravulizumab receive recruitment registry Remdesivir renal respiratory respiratory distress Respiratory distress syndrome routine clinical care Safety screened Screening secondary Serious Adverse Events serum severe acute respiratory distress syndrome coronavirus 2 Severe acute respiratory syndrome severe COVID-19 severe pneumonia SOFA Spain SpO2 Sponsor stratified Study protocol supportive care survival The United States therapy time Treatment treatment-emergent adverse event Ultomiris United Kingdom ventricular Viral website with COVID-19 X-ray [DOI] 10.1186/s13063-020-04548-z PMC 바로가기 [Article Type] Letter
Late histological findings in symptomatic COVID-19 patients A case report7100 Published on 2020-07-102022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] alveolar analyzed Autopsies biopsy bleb Case report Chest conducted cough COVID-19 COVID-19 patient COVID-19 pneumonia distress endothelial Endothelial dysfunction Evidence fatigue feature Fever Ground-glass opacities Hemorrhagic histological histological change include Infection infiltration inflammatory cell intensive care Intubated intubation lack men muscular Nasopharyngeal swab Novel coronavirus pathologic pathological pathology Patient performed pneumothorace positive postoperative pulmonary damage Radiographic specimen symptomatic symptoms onset thrombosis vessel [DOI] 10.1097/MD.0000000000021046 PMC 바로가기 [Article Type] 7100
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19Research Published on 2020-07-032022-10-28 Journal: Respiratory Research [Category] COVID-19, [키워드] 95% CI acute respiratory distress age Analysis caused change China Clinical use collected data correlation count COVID-19 Cox regression Cox regression analysis Critical cut-off D-dimer death Deceased diagnosed dynamic enrolled evaluate Hospital admission Hospitalization hospitalized patient Infection initial Intubated intubated patients intubation Laboratory mortality rate much higher multivariable Cox regression Neutrophil-lymphocyte count ratio NLR non-intubated patient observé outbreak participant Patient patients patients with COVID-19 PCT Prognosis prognostic prognostic biomarker Prognostic factor pulmonary Ratio Result Retrospective study rising risk of death ROC Curve statistically survivor Symptom syndrome the patient utility with COVID-19 Wuhan [DOI] 10.1186/s12931-020-01428-7 PMC 바로가기 [Article Type] Research
Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-06-082022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 6 hour activity Analysis Antiviral effect blinded Chloroquine Complication contraindication Control control group COVID-19 COVID-19 patient COVID-19 PCR test COVID-19 positive patient Date death determine Diabetes Mellitus dissemination dose Dual therapy Efficacy element Elimination expected Follow-up greater Hospital admission hospital discharge Hydroxychloroquine hypertension inherent Intervention Intubated invasive mechanical management Mechanical mechanical ventilation medication MERS monotherapy nitazoxanide number obesity objective Older outcome parallel group participant Patient patients with COVID-19 PCR test percentage Placebo positive patients Presence protocol QT interval QTc randomised randomised controlled trial Randomized Randomly reached receive recruited recruitment reducing required risk factor Sample size SARS-CoV-2 sealed Seven state status Study protocol therapy Toluca treat treated Treatment treatment regimen Trial Ventilation ventilatory support virus website [DOI] 10.1186/s13063-020-04448-2 PMC 바로가기 [Article Type] Letter
High‐dose, short‐term corticosteroids for ARDS caused by COVID ‐19: a case seriesCase Series Published on 2020-06-042022-10-29 Journal: Respirology Case Reports [Category] COVID-19, [키워드] acute respiratory distress Administered administration of corticosteroid Admission ARDS case sery caused Clinical course Clinical management coronavirus disease Corticosteroid corticosteroid therapy COVID COVID‐19 COVID‐19 cytokine early treatment Evidence intravenously Intubated male management mechanical ventilation mechanically ventilated patient median median age Methylprednisolone patients Prevent question Seven syndrome systemic corticosteroid the patient Treatment worsened [DOI] 10.1002/rcr2.596 PMC 바로가기 [Article Type] Case Series